Electroacupuncture as an eosinophil-targeting treatment in ovalbumin-induced allergic rhinitis involving β2-adrenergic receptor in a mouse model - Summary - MDSpire

Electroacupuncture as an eosinophil-targeting treatment in ovalbumin-induced allergic rhinitis involving β2-adrenergic receptor in a mouse model

  • By

  • Tran Van Bao Quach

  • Thanh-Hien Vu Nguyen

  • Ngoc Chi Lan Nguyen

  • Che-Hsuan Lin

  • Yi-Hung Chen

  • June 16, 2026

  • 0 min

Share

Objective:

To investigate whether electroacupuncture (EA) attenuates eosinophilic inflammation in allergic rhinitis (AR) and to explore the underlying neuroimmune mechanisms.

Approach:
    Key Findings:
    • EA reduced nasal rubbing, redness, and olfactory dysfunction, comparable to CLP.
    • Both EA and CLP reduced IL-5, IL-13, and serum OVA-specific IgE levels.
    • Only EA reversed OVA-induced nasal eosinophil infiltration and suppressed RNASE2A expression.
    • Pre-treatment with β2-adrenergic antagonist butoxamine abolished EA's effects on eosinophilic inflammation.
    • EA was associated with elevated plasma norepinephrine and epinephrine levels.
    Interpretation:

    EA reduces eosinophilic inflammation and AR behaviors through β2-adrenergic receptor activation, differing from standard antihistamines that primarily target mast cells.

    Conclusion:

    EA represents a promising complementary intervention for eosinophil-driven allergic rhinitis.

Original Source(s)

Related Content